| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 11.03▼ | 11.01▼ | 11.01▼ | 10.56▲ | 9.33▲ |
| MA10 | 11.03▼ | 11.01▼ | 10.87▲ | 10.16▲ | 7.73▲ |
| MA20 | 11.05▼ | 10.82▲ | 10.58▲ | 9.30▲ | 5.95▲ |
| MA50 | 11.01▼ | 10.57▲ | 10.40▲ | 7.41▲ | 4.13▲ |
| MA100 | 10.89▲ | 10.36▲ | 9.61▲ | 5.71▲ | 4.20▲ |
| MA200 | 10.61▲ | 9.55▲ | 8.89▲ | 4.44▲ | 6.19▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.009▼ | 0.005▲ | 0.039▲ | 0.076▲ | 0.554▲ |
| RSI | 47.158▼ | 62.077▲ | 65.534▲ | 74.350▲ | 81.817▲ |
| STOCH | 54.856 | 68.620 | 90.267▲ | 82.686▲ | 86.804▲ |
| WILL %R | -55.556 | -21.053▲ | -12.371▲ | -4.207▲ | -1.764▲ |
| CCI | -175.000▼ | 48.895 | 78.354 | 105.638▲ | 135.990▲ |
|
Thursday, September 24, 2026 05:57 PM
An influential investment bank resumed its coverage of the company.
|
|
Monday, September 21, 2026 07:17 AM
The awards were granted under Iovance's Amended and Restated 2021 Inducement Plan, which provides for the granting of equity awards to new employees of Iovance by the Company's compensation committee ...
|
|
Friday, August 07, 2026 05:00 PM
Barclays analyst Etzer Darout maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Overweight and raises the price target from $13 to $15. TD Cowen analyst Nicholas Lorusso maintains Iovance ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/09/26 | 10.90 | 11.13 | 10.69 | 11.00 | 12,580,627 |
| 24/09/26 | 10.40 | 10.83 | 10.15 | 10.80 | 11,834,579 |
| 23/09/26 | 10.69 | 10.845 | 10.12 | 10.19 | 15,778,480 |
| 22/09/26 | 10.175 | 10.80 | 10.03 | 10.64 | 15,678,478 |
| 21/09/26 | 10.43 | 10.64 | 10.03 | 10.19 | 13,040,173 |
| 18/09/26 | 10.12 | 10.27 | 9.83 | 10.25 | 22,607,679 |
| 17/09/26 | 10.25 | 10.98 | 9.985 | 10.02 | 24,017,811 |
| 16/09/26 | 9.45 | 9.925 | 9.435 | 9.87 | 19,587,244 |
| 15/09/26 | 9.21 | 9.38 | 8.98 | 9.36 | 11,047,104 |
| 14/09/26 | 8.56 | 9.41 | 8.54 | 9.26 | 21,033,600 |
|
|
||||
|
|
||||
|
|